Trinity Biotech PE Ratio 2010-2025 | TRIB
Current and historical p/e ratio for Trinity Biotech (TRIB) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Trinity Biotech PE ratio as of August 14, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Trinity Biotech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-14 | 1.91 | 0.00 | |
| 2025-03-31 | 0.57 | $-2.93 | 0.00 |
| 2024-12-31 | 0.88 | $-2.82 | 0.00 |
| 2024-09-30 | 1.10 | $-2.26 | 0.00 |
| 2024-06-30 | 2.13 | $-2.70 | 0.00 |
| 2024-03-31 | 2.04 | $-2.79 | 0.00 |
| 2023-12-31 | 2.15 | $-3.17 | 0.00 |
| 2023-09-30 | 3.68 | $-3.75 | 0.00 |
| 2023-06-30 | 4.76 | $-4.05 | 0.00 |
| 2023-03-31 | 4.70 | $-4.70 | 0.00 |
| 2022-12-31 | 4.95 | $-6.45 | 0.00 |
| 2022-09-30 | 5.36 | $-5.45 | 0.00 |
| 2022-06-30 | 6.13 | $-3.80 | 0.00 |
| 2022-03-31 | 5.30 | $-2.55 | 0.00 |
| 2021-12-31 | 7.15 | $0.45 | 15.89 |
| 2021-09-30 | 10.80 | $-0.80 | 0.00 |
| 2021-06-30 | 14.70 | $0.35 | 42.00 |
| 2021-03-31 | 18.80 | $0.60 | 31.33 |
| 2020-12-31 | 19.05 | $-0.10 | 0.00 |
| 2020-09-30 | 10.10 | $-2.90 | 0.00 |
| 2020-06-30 | 10.90 | $-4.30 | 0.00 |
| 2020-03-31 | 5.50 | $-5.25 | 0.00 |
| 2019-12-31 | 5.17 | $-5.10 | 0.00 |
| 2019-09-30 | 6.05 | $-5.35 | 0.00 |
| 2019-06-30 | 8.25 | $-5.40 | 0.00 |
| 2019-03-31 | 14.25 | $-4.35 | 0.00 |
| 2018-12-31 | 11.45 | $-4.20 | 0.00 |
| 2018-09-30 | 20.00 | $-7.60 | 0.00 |
| 2018-06-30 | 25.00 | $-7.65 | 0.00 |
| 2018-03-31 | 25.75 | $-7.60 | 0.00 |
| 2017-12-31 | 25.50 | $-7.45 | 0.00 |
| 2017-09-30 | 28.05 | $-18.10 | 0.00 |
| 2017-06-30 | 30.00 | $-18.30 | 0.00 |
| 2017-03-31 | 29.80 | $-18.05 | 0.00 |
| 2016-12-31 | 34.60 | $-18.60 | 0.00 |
| 2016-09-30 | 66.10 | $0.55 | 120.18 |
| 2016-06-30 | 56.70 | $3.30 | 17.18 |
| 2016-03-31 | 58.30 | $3.35 | 17.40 |
| 2015-12-31 | 58.80 | $4.50 | 13.07 |
| 2015-09-30 | 57.20 | $4.90 | 11.67 |
| 2015-06-30 | 90.30 | $3.15 | 28.67 |
| 2015-03-31 | 95.07 | $3.55 | 26.78 |
| 2014-12-31 | 86.47 | $3.60 | 24.02 |
| 2014-09-30 | 90.23 | $3.65 | 24.72 |
| 2014-06-30 | 113.73 | $2.10 | 54.16 |
| 2014-03-31 | 118.55 | $2.05 | 57.83 |
| 2013-12-31 | 123.00 | $2.05 | 60.00 |
| 2013-09-30 | 106.46 | $2.10 | 50.70 |
| 2013-06-30 | 82.44 | $3.75 | 21.98 |
| 2013-03-31 | 81.62 | $3.85 | 21.20 |
| 2012-12-31 | 69.72 | $3.90 | 17.88 |
| 2012-09-30 | 60.78 | $3.80 | 15.99 |
| 2012-06-30 | 58.02 | $3.70 | 15.68 |
| 2012-03-31 | 50.90 | $3.60 | 14.14 |
| 2011-12-31 | 48.56 | $3.50 | 13.88 |
| 2011-09-30 | 43.70 | $3.45 | 12.67 |
| 2011-06-30 | 47.42 | $3.25 | 14.59 |
| 2011-03-31 | 42.96 | $14.40 | 2.98 |
| 2010-12-31 | 40.35 | $14.30 | 2.82 |
| 2010-09-30 | 28.99 | $14.20 | 2.04 |
| 2010-06-30 | 27.85 | $14.20 | 1.96 |
| 2010-03-31 | 24.96 | $2.90 | 8.61 |
| 2009-12-31 | 18.50 | $2.75 | 6.73 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.034B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $225.007B | 26.38 |
| Boston Scientific (BSX) | United States | $154.324B | 36.80 |
| Stryker (SYK) | United States | $144.711B | 29.46 |
| EssilorLuxottica (ESLOY) | France | $142.399B | 0.00 |
| Medtronic (MDT) | Ireland | $117.900B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.114B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.571B | 24.87 |
| ResMed (RMD) | United States | $41.687B | 29.81 |
| Agilent Technologies (A) | United States | $33.767B | 22.01 |
| GE HealthCare Technologies (GEHC) | United States | $33.630B | 15.81 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $26.220B | 17.34 |
| Insulet (PODD) | United States | $22.229B | 74.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.230B | 12.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.039B | 0.00 |
| Baxter (BAX) | United States | $12.558B | 9.70 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.773B | 28.55 |
| Lantheus Holdings (LNTH) | United States | $3.704B | 10.01 |
| Envista Holdings (NVST) | United States | $3.460B | 24.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.179B | 14.10 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $2.762B | 18.81 |
| Haemonetics (HAE) | United States | $2.521B | 11.25 |
| LeMaitre Vascular (LMAT) | United States | $2.169B | 46.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.969B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.827B | 78.46 |
| QuidelOrtho (QDEL) | United States | $1.762B | 11.09 |
| AtriCure (ATRC) | United States | $1.760B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.299B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.84 |
| BioLife Solutions (BLFS) | United States | $1.213B | 2532.00 |
| Neogen (NEOG) | United States | $1.195B | 18.97 |
| Acuren (TIC) | United States | $1.153B | 0.00 |
| InMode (INMD) | Israel | $0.903B | 8.35 |
| Valneva SE (VALN) | France | $0.891B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.820B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| SNDL (SNDL) | Canada | $0.554B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.543B | 0.00 |
| Surmodics (SRDX) | United States | $0.538B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| Cresco Labs (CRLBF) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.447B | 15.40 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.417B | 3.70 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.357B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.356B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Omeros (OMER) | United States | $0.254B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 49.35 |
| Vireo Growth (VREOF) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.209B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 15.21 |
| FitLife Brands (FTLF) | United States | $0.152B | 18.67 |
| Biote (BTMD) | United States | $0.147B | 4.89 |
| TriSalus Life Sciences (TLSI) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.14 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.080B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 35.37 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Veru (VERU) | United States | $0.054B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 33.33 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |